Basic information
- CAS
55453-87-7- Standard SMILES
O=C(O)Cc1ccc2c(c1)C(=O)c1ccccc1CO2- InChIKey
QFGMXJOBTNZHEL-UHFFFAOYSA-N- Molecular formula
- C16H12O4
- Average molar mass
- 268.26 g/mol
- Monoisotopic mass
- 268.07355886
Overview
Isoxepac is a dibenzooxazepine.
Names & identifiers
- Preferred name
- Isoxepac
- IUPAC
- 2-(11-oxo-6H-benzo[c][1]benzoxepin-2-yl)acetic acid
- English name
- Isoxepac
- Molecular formula
- C16H12O4
- Molecular weight
- 268.26
Names & synonyms
Show more names
Database identifiers
- CAS
55453-87-7- PubChem CID
- 41448
- DTXSID
DTXSID8057772- ChEMBL
CHEMBL33211- ChEBI
CHEBI:135102- UNII
- 2KH283Q0Z5
- EC Number
- 611-268-9
- Nikkaji
- J11.446D
Properties
Computed structural properties
- XLogP
- 2.4
- Topological polar surface area
- 63.6 Ų
- Hydrogen bond donors
- 1
- Hydrogen bond acceptors
- 4
- Rotatable bonds
- 2
- Heavy atoms
- 20
- Formal charge
- 0
- Complexity
- 392
Physicochemical properties
- Melting point
- 130 · 130-132°C
- Boiling point
- 528.2 · 528.2±50.0 °C(Predicted)
- Density
- 1.39 g/cm3 · 1.39 g/cm3
- storage temp.
- Sealed in dry,Room Temperature
- solubility
- soluble in Methanol
- pka
- 4.24 · 4.24±0.10(Predicted)
- form
- Solid
- color
- White to Light yellow to Light orange
- Merck
- 14 · 14,5237
- Major Application
- pharmaceutical (small molecule)
- InChI
- InChI=1S/C16H12O4/c17-15(18)8-10-5-6-14-13(7-10)16(19)12-4-2-1-3-11(12)9-20-14/h1-7H,8-9H2,(H,17,18)
- InChIKey
- QFGMXJOBTNZHEL-UHFFFAOYSA-N
- SMILES
- O1CC2=CC=CC=C2C(=O)C2=CC(CC(O)=O)=CC=C12
- CAS DataBase Reference
- 55453 · 55453-87-7(CAS DataBase Reference)
- FDA UNII
- 2 KH283Q0Z5 · 2KH283Q0Z5
- UNSPSC Code
- 41116107 · 41116107
- NACRES
- 24 · NA.24
- Symbol(GHS)
- 6 · GHS06
- Signal word
- Danger
- Hazard statements
- 301 · H301+H311-H315-H319
- Precautionary statements
- 501 · P501-P270-P264-P280-P337+P313-P305+P351+P338-P361+P364-P332+P313-P301+P310+P330-P302+P352+P312-P405
- Hazard Codes
- T
- Risk Statements
- 25 · 25-62
- Safety Statements
- 36 · 36/37-45
- RIDADR
- 2811 · UN 2811 6.1 / PGIII
- WGK Germany
- 3 · WGK 3
- RTECS
- 4110000 · HQ4110000
- HazardClass
- 6.1 · 6.1
- PackingGroup
- III
- HS Code
- 2932996560 · 2932996560
- Storage Class
- 6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
- Hazard Classifications
- 3 OralRepr · Acute Tox. 3 OralRepr. 2STOT RE 1
- Toxicity
- 50 orally · LD50 orally in rats: 199 mg/kg (Ueno)
Safety & regulation
GHS classification
GHS Classification
Danger
H301 (85.7%): Toxic if swallowed [Danger Acute toxicity, oral]
P203, P260, P261, P264, P264+P265, P270, P271, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 7 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Hazard information
Safety data
- wgk
- WGK 3
- rtecs
- HQ4110000
- ridadr
- UN 2811 6.1 / PGIII
- hs_code
- 2932996560
- Toxicity
- LD50 orally in rats: 199 mg/kg (Ueno)
- risk_code
- 25-62
- Signal word
- Danger
- Symbol(GHS)
- GHS06
- hazard_code
- T
- safety_code
- 36/37-45
- hazard_class
- 6.1
- Storage Class
- 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
- packing_group
- III
- Hazard statements
- H301+H311-H315-H319
- Hazard Classifications
- Acute Tox. 3 OralRepr. 2STOT RE 1
- Precautionary statements
- P501-P270-P264-P280-P337+P313-P305+P351+P338-P361+P364-P332+P313-P301+P310+P330-P302+P352+P312-P405
Chemistry & industry
Applications
UsesIsoxepac is a non-steroidal anti-inflammatory with analgesic and antipyretic activity. It is more slowly absorbed and eliminated in the rat and rabbit after oral dosing than in the dog, rhesus monkey and man.It can be used to treat allergic rhinitis, urticaria, and skin diseases with itching symptoms.
Preparation methods
PreparationIsoxic acid is an important intermediate in the synthesis of the new preferred anti-allergic drug, olopatadine hydrochloride, preparation method of isoxepac:(1) condensation: prepare p-hydroxyphenylaceticacid 8-12 part, phthalide 6-12 part, sodium methylate 8-12 part by weight; Dissolve with DMAC and to add said sodium methylate behind said p-hydroxyphenylaceticacid and the phthalide; Be that 0.1-10Pa is heated to 80-170 ℃ of reaction 3-10h at pressure then; Regulate the pH value to 1-5,4-(2-carboxyl benzyloxy) toluylic acid is separated out in crystallization;(2) cyclization: with Glacial acetic acid min. 99.5 dissolving step (1) gained 4-(2-carboxyl benzyloxy) toluylic acid, adding 3-52 weight part polyphosphoric acid again, is that 0.1-10Pa is heated to 30-100 ℃ of reaction 3-12h at pressure, and crystallisation by cooling gets the Isoxepac bullion then;(3) purify: behind the said Isoxepac bullion of acetic acid ethyl dissolution, refining decolouring gets the Isoxepac product.https://patents.google.com/patent/CN102838582A/en
Upstream & downstream products
Upstream raw materials
Downstream products
Suppliers100 total
Additional notes
DefinitionChEBI: Isoxepac is a dibenzooxazepine.
Related reactions
Compound notes
Loading…